Business · 14. 11. 2026.1 min read

CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List

Lokalni automatski prijevod · Izvorni jezik izvora

Illustration generated by Business News; it is not a source photograph.

Sažetak

SHANGHAI, Nov. 14, 2026 — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel…

Izvorni jezik izvora: PR Newswire — Global News ReleasesPročitajte original →

Related companies

STOCK
Open profile →Explore businesses on Business Maps →
Shanghai
Open profile →Explore businesses on Business Maps →
Shanghai
Open profile →Explore businesses on Business Maps →